WO2018119663A1 - Diabetes detection method and diabetes detection system - Google Patents

Diabetes detection method and diabetes detection system Download PDF

Info

Publication number
WO2018119663A1
WO2018119663A1 PCT/CN2016/112371 CN2016112371W WO2018119663A1 WO 2018119663 A1 WO2018119663 A1 WO 2018119663A1 CN 2016112371 W CN2016112371 W CN 2016112371W WO 2018119663 A1 WO2018119663 A1 WO 2018119663A1
Authority
WO
WIPO (PCT)
Prior art keywords
risk
blood glucose
diabetes
subject
level
Prior art date
Application number
PCT/CN2016/112371
Other languages
French (fr)
Chinese (zh)
Inventor
珍 玛丽 比丽尔理查德
Original Assignee
创新精密仪器有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 创新精密仪器有限公司 filed Critical 创新精密仪器有限公司
Priority to PCT/CN2016/112371 priority Critical patent/WO2018119663A1/en
Publication of WO2018119663A1 publication Critical patent/WO2018119663A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue

Definitions

  • the present invention belongs to the field of diabetes detection technology, and more particularly to a diabetes detection method and a diabetes detection system.
  • the diagnosis of diabetes is based primarily on criteria set by the American Diabetes Association (ADA) to determine whether you have diabetes or pre-diabetes.
  • One type of diagnosis is the Fasting Plasma Glucose (FPG) check, which is highly accepted due to its ease of implementation and low cost. Fasting is defined as the absence of any calories in at least 8 hours. If the subject's fasting blood glucose level is between 100 and 125 mg/dL, it is a type of pre-diabetes called Impaired Fasting Glucose (IFG), which means that although there is no diabetes, It is very likely to develop into type 2 diabetes. If the second check on another day determines that the blood glucose level is above 126 mg/dL, it means diabetes.
  • FPG Fasting Plasma Glucose
  • OGTT Oral Glucose Tolerance Test
  • ITT Impaired Glucose Tolerance
  • An object of the present invention is to provide a method for detecting diabetes, which aims to solve the problem that the prior art lacks a simple and easy-to-use method for detecting diabetes risk.
  • the present invention provides a diabetes detecting method for detecting a risk of diabetes in a subject, comprising the following steps:
  • the above-mentioned diabetes detection method is used to detect sputum, which first acquires physiological information of the subject, and then determines whether the subject takes up the glucose solution, and if so, confirms receipt of the glucose solution input by the subject. After the information, after the predetermined time, the subject is prompted to measure the first blood glucose level; if not, the fasting blood glucose value and the first blood glucose value of the subject are obtained; finally, according to the physiological information of the subject, the fasting blood glucose level and the first A blood sugar level determines the degree of risk of the subject having diabetes, and the degree of the risk is displayed to the ordinary person. Therefore, by the above-mentioned diabetes detection method, the average person can easily and easily know the degree of risk of having diabetes. It is beneficial for the subjects to detect diabetes by themselves.
  • Another object of the present invention is to provide a diabetes detection system, comprising:
  • a blood glucose measuring device configured to acquire a fasting blood sugar level and a first blood sugar level of the subject
  • an electronic device configured to acquire physiological information of the subject and determine whether the subject ingests a glucose solution, and after receiving confirmation information of the ingested glucose solution input by the subject, After the predetermined time, the subject is prompted to measure the first blood glucose level, and then according to the physiological information of the subject, the fasting blood glucose level and the first blood glucose level, determining the risk degree of the subject suffering from diabetes, Showing the degree of risk;
  • the electronic device is connected to a blood glucose measuring device.
  • detecting ⁇ by using the above-mentioned diabetes detection system, which first acquires physiological information and fasting blood glucose level of the subject via the electronic device, and then determines whether the subject takes up the glucose solution via the electronic device, and if so, via the electronic device After receiving the confirmation information of the ingested glucose solution input by the subject, after a predetermined time, the subject is prompted to measure the first blood glucose level by using the blood glucose measuring device, and then according to the physiological information of the subject and the fasting blood glucose value via the electronic device. And the first blood glucose level determines the degree of risk of the subject having diabetes, and displays the risk level to an ordinary person via an electronic device. Therefore, with the above-described diabetes detecting device, the average person can easily and easily know the degree of risk of having diabetes, and it is advantageous for the subject to self-detect diabetes.
  • FIG. 1 is a flowchart of a diabetes detection method according to an embodiment of the present invention.
  • FIG. 2 is a flowchart of steps performed by the diabetes detection method according to an embodiment of the present invention for a female subject or a female who is not pregnant;
  • FIG. 3 is a schematic structural diagram of a diabetes detecting system according to an embodiment of the present invention.
  • FIGS. 1 to 3 a preferred embodiment of the present invention is provided.
  • the diabetes detecting method provided in the embodiment is used for detecting a subject suffering from diabetes.
  • the risks include the following steps:
  • step S3 If yes, proceed to step S3;
  • the above-mentioned diabetes detection method is used to detect sputum, which first acquires the physiological information of the subject and the fasting blood glucose level, and then determines whether the subject takes up the glucose solution, and if so, receives the ingested input by the subject. After confirming the glucose solution, the subject is prompted to measure the first blood glucose level after a predetermined time, and then the risk level of the subject is determined according to the physiological information of the subject, the fasting blood glucose level and the first blood glucose level. And show the degree of risk to ordinary people. Therefore, through the above-mentioned diabetes detection method, the average person can easily and easily know the degree of risk of having diabetes, and it is advantageous for the subject to self-test diabetes.
  • physiological information includes males, non-pregnant women, and pregnant women.
  • the measurement of the first blood glucose level was performed 2 hours after the subject ingested the glucose solution.
  • the step of determining the risk level of the subject having diabetes includes:
  • step B determines whether the fasting blood glucose value is less than 100 mg / deciliter, and if so, step B is performed, and if not, step D is performed;
  • step B determining whether the first blood glucose level is less than 140 mg / deciliter, and if so, determining that the risk level is a low risk, if not, performing step C;
  • step E determining whether the fasting blood glucose value is between 100 and 125 mg / deciliter, and if so, performing step E
  • step E determining whether the first blood glucose level is less than 140 mg / deciliter, and if so, determining that the risk level is moderate risk, and if not, performing step F;
  • F determining whether the first blood glucose level is between 140 and 199 mg / deciliter, and if so, determining that the risk level is a moderate risk, and if not, determining that the risk level is a high risk;
  • step H determining whether the fasting blood glucose level is above 126 mg / deciliter, and if so, performing step H, if no
  • step I determining whether the first blood glucose level is less than 140 mg / deciliter, and if so, determining that the risk level is moderate risk, and if not, performing step I;
  • [0046] Determine whether the first blood glucose level is between 140 and 199 mg / deciliter, and if so, determine that the risk level is a high risk, and if not, determine the risk level as a high risk.
  • the risk level is determined to be a low risk
  • the risk level is determined to be a moderate risk
  • the risk level is determined to be a high risk
  • the fasting blood glucose value is between 100 and 125 mg / deciliter, and the first blood glucose value is less than 140 mg / deciliter, the degree of risk is determined to be a moderate risk
  • the degree of risk is determined to be a moderate risk
  • the fasting blood glucose level is between 100 and 125 mg / deciliter, and the first blood glucose level is above 200 mg / deciliter, the degree of risk is determined to be a high risk;
  • the risk level is determined to be moderate risk;
  • the fasting blood glucose level is above 126 mg/dl, and the first blood glucose value is between 140 and 199 mg/dl, the risk level is determined to be a high risk;
  • the fasting blood glucose level is above 126 mg / deciliter and the first blood glucose level is above 200 mg / deciliter, then the degree of risk is determined to be a high risk.
  • the male or the non-pregnant female can clearly and accurately know the degree of risk of having diabetes, which does not have professional medical knowledge. Ordinary people will help to improve their understanding of the degree of diabetes risk represented by the test results, to facilitate their treatment, and to avoid missing valuable treatment opportunities.
  • the step of determining the risk level of the subject having diabetes includes:
  • the risk level is a low risk or a medium risk.
  • the first blood glucose level of 1 hour after the predetermined daytime is greater than 180 mg/dl
  • the first blood glucose level of 2 hours after the predetermined daytime is greater than 155 mg/dl;
  • the first blood glucose level of 3 hours after the predetermined daytime is greater than 140 mg/dl.
  • the risk level is determined to be a high risk
  • the fasting blood glucose value is greater than 95 mg / deciliter, and the first blood glucose value is less than 15 after a predetermined daytime of 2 hours
  • the step of determining the risk degree of the subject having diabetes may specifically include: [0071] Perform the following steps on the female subject who is pregnant:
  • the risk level is a low risk or a moderate risk.
  • the first predetermined time is different from the second predetermined time
  • the first preset value is different from the second preset value
  • the first predetermined time may be 1 hour or 2 hours
  • the second predetermined time may be 3 hours
  • the first preset value may be 180 mg/dl or 155 mg/dl.
  • the second preset value can be 140 mg / dl, so that you can have:
  • the first blood glucose level is greater than 180 mg/dl when the first predetermined time interval is 1 hour, and the first blood glucose value is greater than 140 mg/minute after the second predetermined day is 3 hours. Ascending, determining that the risk level is a high risk;
  • the first blood glucose level is greater than 155 mg/dl when the first predetermined day is 2 hours, and the first blood glucose value is greater than 140 mg/min after the second predetermined day is 3 hours. Ascension, the degree of risk is determined to be a high risk.
  • the first predetermined time may be 1 hour
  • the second predetermined time may be 2 hours
  • the first preset value may be 180 mg/dl
  • the second preset value may be 155. Mg/dl, so that you can have:
  • the first blood glucose level is greater than 180 mg/dl when the first predetermined time interval is 1 hour, and the first blood glucose value is greater than 155 mg/minute after the second predetermined time interval is 2 hours. Ascension, the degree of risk is determined to be a high risk.
  • the pregnant woman can clearly and accurately know the degree of risk of having diabetes, which is common to ordinary people who do not have professional medical knowledge. It helps to improve their understanding of the degree of diabetes risk represented by the test results, to facilitate their treatment, and to avoid missing valuable treatment opportunities.
  • the embodiment further provides a diabetes detection system 10, including:
  • the blood glucose measuring device 100 is configured to acquire a fasting blood sugar level and a first blood sugar level of the subject;
  • the electronic device 110 configured to acquire physiological information of the subject, determine whether the subject takes up the glucose solution, and receive confirmation of the ingested glucose solution input by the subject After the information, after the predetermined time, the subject is prompted to measure the first blood glucose level, and then the subject is determined to have diabetes according to the physiological information of the subject, the fasting blood glucose level and the first blood glucose level.
  • the degree of risk showing the degree of risk;
  • the electronic device 110 is connected to the blood glucose measuring device 100.
  • the above-described diabetes detection system 10 performs detection, which first acquires the physiological information of the subject and the fasting blood glucose level via the electronic device 110, and then determines whether the subject takes the glucose solution via the electronic device 110, and if so, via After receiving the confirmation information of the ingested glucose solution input by the subject, the electronic device 110 prompts the subject to measure the first blood glucose level by using the blood glucose measuring device 100, and then, according to the subject, via the electronic device 110.
  • the physiological information, the fasting blood glucose level, and the first blood glucose level determine the degree of risk of the subject having diabetes, and the risk level is displayed to the ordinary person via the electronic device 110. Therefore, with the above-described diabetes detecting device, the average person can realize the risk of having diabetes easily and easily, and it is advantageous for the subject to self-detect diabetes.
  • physiological information includes males, non-pregnant women, and pregnant women.
  • the electronic device 110 and the blood glucose measuring device 100 transmit and receive information by way of wireless communication 120.
  • the blood glucose detecting device may be a blood glucose meter or a blood glucose tester.
  • the wireless communication 120 includes infrared communication, Bluetooth, ZigBee, GSM, CDMA, T
  • the electronic device 110 is a mobile phone, a tablet computer or a computer.

Abstract

A diabetes detection method, comprising the following steps: S1, obtaining physiological information and a fasting blood glucose value of a test subject; S2, determining whether or not the test subject takes a glucose solution; if yes, executing step S3, and if not, returning to step S1; S3, after receiving confirmation information that the glucose solution has been taken, which is inputted by the test subject, prompting the test subject to measure a first blood glucose value after a predetermined time, and then determining a degree of risk of the test subject suffering from diabetes according to the physiological information, the fasting blood glucose value and the first blood glucose value of the test subject, and displaying the degree of risk. By means of said diabetes detection method, ordinary people may simply and easily know the degree of risk of suffering from diabetes thereof, which may help test subjects to detect diabetes autonomously. Further provided is a diabetes detection system, which comprises a blood glucose measuring device and an electronic device.

Description

糖尿病检测方法及糖尿病检测系统 技术领域  Diabetes detection method and diabetes detection system
[0001] 本发明属于糖尿病检测技术的领域, 尤其涉及糖尿病检测方法及糖尿病检测系 统。  [0001] The present invention belongs to the field of diabetes detection technology, and more particularly to a diabetes detection method and a diabetes detection system.
背景技术  Background technique
[0002] 糖尿病的诊断主要依据美国糖尿病学会 (ADA)所订定的标准, 来确认是否患有 糖尿病或前期糖尿病。 一种诊断方式为空腹血糖 (Fasting Plasma Glucose, FPG ) 检査, 由于其容易执行、 费用较低, 所以患者接受度较高。 空腹的定义为至 少 8小吋内未摄取任何卡路里。 若受测者的空腹血糖值在 100至 125 mg/dL之间, 则是属于一种名为空腹葡萄糖耐受不良 (Impaired Fasting Glucose, IFG) 的前期 糖尿病, 代表现在虽然尚未患有糖尿病, 但很有可能发展成第二型糖尿病。 若 另一日的第二次检査确定血糖值在 126 mg/dL以上, 即代表患有糖尿病。  [0002] The diagnosis of diabetes is based primarily on criteria set by the American Diabetes Association (ADA) to determine whether you have diabetes or pre-diabetes. One type of diagnosis is the Fasting Plasma Glucose (FPG) check, which is highly accepted due to its ease of implementation and low cost. Fasting is defined as the absence of any calories in at least 8 hours. If the subject's fasting blood glucose level is between 100 and 125 mg/dL, it is a type of pre-diabetes called Impaired Fasting Glucose (IFG), which means that although there is no diabetes, It is very likely to develop into type 2 diabetes. If the second check on another day determines that the blood glucose level is above 126 mg/dL, it means diabetes.
[0003] 另一种诊断方式为口服葡萄糖耐受试验 (Oral Glucose Tolerance Test, OGTT) 。 进行口服葡萄糖耐受试验之前, 需先立即测量空腹血糖值。 然后, 喝下含有 7 5克葡萄糖的糖水, 喝完 2小吋后再测量一次血糖。 若您喝下糖水后 2小吋的血糖 值在 140至 199 mg/dL之间, 则称为葡萄糖耐受不良 (Impaired Glucose Tolerance , IGT) , 也就是糖尿病前期, 代表您现在虽然还未罹患糖尿病, 但很有可能发 展成第二型糖尿病。 若另一日的第二次检査确定 2小吋后的血糖值在 200 mg/dL以 上, 即代表患有糖尿病。  [0003] Another diagnostic method is the Oral Glucose Tolerance Test (OGTT). The fasting blood glucose level should be measured immediately before the oral glucose tolerance test. Then, drink the sugar water containing 75 grams of glucose, and measure the blood sugar after drinking for 2 hours. If you drink 2 hours after drinking syrup, the blood sugar level is between 140 and 199 mg/dL, which is called Impaired Glucose Tolerance (IGT), which is the pre-diabetes period. It means that you have not yet developed diabetes. , but it is very likely to develop into type 2 diabetes. If the second check on another day determines that the blood glucose level after 2 hours is above 200 mg/dL, it means diabetes.
[0004] 然而, 目前, 普通人在进行 FPG或 0GTT检测吋, 往往缺少一套简单且操作容 易的工具来帮助自己检测患有糖尿病的风险。  [0004] However, at present, ordinary people are often lacking a simple and easy-to-use tool to help them detect the risk of diabetes after performing FPG or 0GTT testing.
技术问题  technical problem
[0005] 本发明的目的在于提供糖尿病检测方法, 旨在解决现有技术缺少一种简单、 操 作容易的糖尿病风险度检测方法的问题。  [0005] An object of the present invention is to provide a method for detecting diabetes, which aims to solve the problem that the prior art lacks a simple and easy-to-use method for detecting diabetes risk.
问题的解决方案  Problem solution
技术解决方案 [0006] 为解决上述技术问题, 本发明提供了糖尿病检测方法, 用于检测受试对象患有 糖尿病的风险, 包括以下步骤: Technical solution [0006] In order to solve the above technical problems, the present invention provides a diabetes detecting method for detecting a risk of diabetes in a subject, comprising the following steps:
[0007] Sl、 获取所述受试对象的生理信息和空腹血糖值; [0007] Sl, obtaining physiological information of the subject and a fasting blood glucose value;
[0008] S2、 判断所述受试对象是否摄取葡萄糖溶液;  [0008] S2, determining whether the subject takes up a glucose solution;
[0009] 若是, 则执行步骤 S3; [0009] If yes, proceed to step S3;
[0010] 若否, 则返回步骤 S1 ; [0010] If no, return to step S1;
[0011] S3、 于接收所述受试对象所输入的已摄取葡萄糖溶液的确认信息后, 经过预定 吋间, 提示所述受试对象测量第一血糖值, 再根据所述受试对象的生理信息、 空腹血糖值及第一血糖值, 决定所述受试对象患有糖尿病的风险程度, 显示所 述风险程度。  [0011] S3, after receiving the confirmation information of the ingested glucose solution input by the subject, after a predetermined time, the subject is prompted to measure the first blood glucose level, and then according to the physiological condition of the subject The information, the fasting blood glucose level, and the first blood glucose level determine the degree of risk of the subject having diabetes, indicating the degree of the risk.
[0012] 本发明提供的糖尿病检测方法的有益效果:  [0012] The beneficial effects of the diabetes detection method provided by the present invention:
[0013] 采用上述糖尿病检测方法进行检测吋, 其先获取受试对象的生理信息, 然后, 判断受试对象是否摄取葡萄糖溶液, 如果是, 于接收受试对象所输入的已摄取 葡萄糖溶液的确认信息后, 经过预定吋间, 提示受试对象测量第一血糖值; 如 果否, 获取受试对象的空腹血糖值及第一血糖值; 最后, 根据受试对象的生理 信息、 空腹血糖值及第一血糖值, 决定受试对象患有糖尿病的风险程度, 并将 该风险程度显示给普通人, 因此, 通过上述糖尿病检测方法, 普通人可以实现 简单、 容易地知道自己患有糖尿病的风险程度, 有利于受试对象自行检测糖尿 病。  [0013] The above-mentioned diabetes detection method is used to detect sputum, which first acquires physiological information of the subject, and then determines whether the subject takes up the glucose solution, and if so, confirms receipt of the glucose solution input by the subject. After the information, after the predetermined time, the subject is prompted to measure the first blood glucose level; if not, the fasting blood glucose value and the first blood glucose value of the subject are obtained; finally, according to the physiological information of the subject, the fasting blood glucose level and the first A blood sugar level determines the degree of risk of the subject having diabetes, and the degree of the risk is displayed to the ordinary person. Therefore, by the above-mentioned diabetes detection method, the average person can easily and easily know the degree of risk of having diabetes. It is beneficial for the subjects to detect diabetes by themselves.
[0014] 本发明另一目的在于提供糖尿病检测系统, 包括:  [0014] Another object of the present invention is to provide a diabetes detection system, comprising:
[0015] 血糖测量装置, 用于获取所述受试对象的空腹血糖值及第一血糖值; [0015] a blood glucose measuring device, configured to acquire a fasting blood sugar level and a first blood sugar level of the subject;
[0016] 以及电子装置, 用于获取所述受试对象的生理信息和判断所述受试对象是否摄 取葡萄糖溶液, 且于接收所述受试对象所输入的已摄取葡萄糖溶液的确认信息 后, 经过预定吋间, 提示所述受试对象测量第一血糖值, 再根据所述受试对象 的生理信息、 空腹血糖值及第一血糖值, 决定所述受试对象患有糖尿病的风险 程度, 显示所述风险程度; And an electronic device, configured to acquire physiological information of the subject and determine whether the subject ingests a glucose solution, and after receiving confirmation information of the ingested glucose solution input by the subject, After the predetermined time, the subject is prompted to measure the first blood glucose level, and then according to the physiological information of the subject, the fasting blood glucose level and the first blood glucose level, determining the risk degree of the subject suffering from diabetes, Showing the degree of risk;
[0017] 所述电子装置和血糖测量装置连接。 [0017] The electronic device is connected to a blood glucose measuring device.
发明的有益效果 有益效果 Advantageous effects of the invention Beneficial effect
[0018] 本发明提供的糖尿病检测系统的有益效果:  [0018] The beneficial effects of the diabetes detection system provided by the present invention:
[0019] 采用上述糖尿病检测系统进行检测吋, 其先经由电子装置获取受试对象的生理 信息和空腹血糖值, 然后, 经由电子装置判断受试对象是否摄取葡萄糖溶液, 如果是, 经由电子装置于接收受试对象所输入的已摄取葡萄糖溶液的确认信息 后, 经过预定吋间, 提示受试对象采用血糖测量装置测量第一血糖值, 再经由 电子装置根据受试对象的生理信息、 空腹血糖值及第一血糖值, 决定受试对象 患有糖尿病的风险程度, 并经由电子装置将该风险程度显示给普通人。 因此, 通过上述糖尿病检测装置, 普通人可以实现简单、 容易地知道自己患有糖尿病 的风险程度, 有利于受试对象自行检测糖尿病。  [0019] detecting 吋 by using the above-mentioned diabetes detection system, which first acquires physiological information and fasting blood glucose level of the subject via the electronic device, and then determines whether the subject takes up the glucose solution via the electronic device, and if so, via the electronic device After receiving the confirmation information of the ingested glucose solution input by the subject, after a predetermined time, the subject is prompted to measure the first blood glucose level by using the blood glucose measuring device, and then according to the physiological information of the subject and the fasting blood glucose value via the electronic device. And the first blood glucose level determines the degree of risk of the subject having diabetes, and displays the risk level to an ordinary person via an electronic device. Therefore, with the above-described diabetes detecting device, the average person can easily and easily know the degree of risk of having diabetes, and it is advantageous for the subject to self-detect diabetes.
对附图的简要说明  Brief description of the drawing
附图说明  DRAWINGS
[0020] 图 1是本发明实施例提供的糖尿病检测方法的流程图;  1 is a flowchart of a diabetes detection method according to an embodiment of the present invention;
[0021] 图 2是本发明实施例提供的糖尿病检测方法的对所述受试对象为男性或未怀孕 的女性执行的步骤的流程图;  2 is a flowchart of steps performed by the diabetes detection method according to an embodiment of the present invention for a female subject or a female who is not pregnant;
[0022] 图 3是本发明实施例提供的糖尿病检测系统的结构示意图。 3 is a schematic structural diagram of a diabetes detecting system according to an embodiment of the present invention.
本发明的实施方式 Embodiments of the invention
[0023] 为了使本发明的目的、 技术方案及优点更加清楚明白, 以下结合附图及实施例 , 对本发明进行进一步详细说明。 应当理解, 此处所描述的具体实施例仅仅用 以解释本发明, 并不用于限定本发明。  The present invention will be further described in detail below with reference to the accompanying drawings and embodiments. It is understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
[0024] 如图 1~3所示, 为本发明提供的较佳实施例。  [0024] As shown in FIGS. 1 to 3, a preferred embodiment of the present invention is provided.
[0025] 需要说明的是, 当元件被称为 "固定于"或"设置于"另一个元件, 它可以直接在 另一个元件上或者间接在该另一个元件上。 当一个元件被称为是 "连接于"另一个 元件, 它可以是直接连接到另一个元件或间接连接至该另一个元件上。  [0025] It is to be noted that when an element is referred to as being "fixed" or "in" another element, it can be directly on the other element or indirectly. When an element is referred to as being "connected" to another element, it can be connected directly to the other element or indirectly connected to the other element.
[0026] 还需要说明的是, 本实施例中的左、 右、 上、 下等方位用语, 仅是互为相对概 念或是以产品的正常使用状态为参考的, 而不应该认为是具有限制性的。  It should be noted that the left, right, upper, lower, and the like orientations in this embodiment are only relative concepts or reference to the normal use state of the product, and should not be considered as having limitations. Sexual.
[0027] 如图 1所示, 本实施例提供的糖尿病检测方法, 用于检测受试对象患有糖尿病 的风险, 包括以下步骤: [0027] As shown in FIG. 1 , the diabetes detecting method provided in the embodiment is used for detecting a subject suffering from diabetes. The risks include the following steps:
[0028] Sl、 获取所述受试对象的生理信息和空腹血糖值;  [0028] Sl, obtaining physiological information of the subject and a fasting blood glucose value;
[0029] S2、 判断所述受试对象是否摄取葡萄糖溶液; [0029] S2, determining whether the subject takes up a glucose solution;
[0030] 若是, 则执行步骤 S3; [0030] If yes, proceed to step S3;
[0031] 若否, 则返回步骤 S1 ; [0031] If no, return to step S1;
[0032] S3、 于接收所述受试对象所输入的已摄取葡萄糖溶液的确认信息后, 经过预定 吋间, 提示所述受试对象测量第一血糖值, 再根据所述受试对象的生理信息、 空腹血糖值及第一血糖值, 决定所述受试对象患有糖尿病的风险程度, 显示所 述风险程度。  [0032] S3, after receiving the confirmation information of the ingested glucose solution input by the subject, after a predetermined time, the subject is prompted to measure the first blood glucose level, and then according to the physiological condition of the subject The information, the fasting blood glucose level, and the first blood glucose level determine the degree of risk of the subject having diabetes, indicating the degree of the risk.
[0033] 采用上述糖尿病检测方法进行检测吋, 其先获取受试对象的生理信息和空腹血 糖值, 然后, 判断受试对象是否摄取葡萄糖溶液, 如果是, 于接收受试对象所 输入的已摄取葡萄糖溶液的确认信息后, 经过预定吋间, 提示受试对象测量第 一血糖值, 再根据受试对象的生理信息、 空腹血糖值及第一血糖值, 决定受试 对象患有糖尿病的风险程度, 并将该风险程度显示给普通人。 因此, 通过上述 糖尿病检测方法, 普通人可以实现简单、 容易地知道自己患有糖尿病的风险程 度, 有利于受试对象自行检测糖尿病。  [0033] The above-mentioned diabetes detection method is used to detect sputum, which first acquires the physiological information of the subject and the fasting blood glucose level, and then determines whether the subject takes up the glucose solution, and if so, receives the ingested input by the subject. After confirming the glucose solution, the subject is prompted to measure the first blood glucose level after a predetermined time, and then the risk level of the subject is determined according to the physiological information of the subject, the fasting blood glucose level and the first blood glucose level. And show the degree of risk to ordinary people. Therefore, through the above-mentioned diabetes detection method, the average person can easily and easily know the degree of risk of having diabetes, and it is advantageous for the subject to self-test diabetes.
[0034] 细化地, 为了使得上述糖尿病检测方法适用的受试对象更为广泛, 生理信息包 括男性、 未怀孕的女性和怀孕的女性。  [0034] In detail, in order to make the above-mentioned diabetes detection method applicable to a wider range of subjects, physiological information includes males, non-pregnant women, and pregnant women.
[0035] 为了准备测量第一血糖值, 其预定吋间为 2小吋。 这样, 在受试对象摄取葡萄 糖溶液后的 2小吋, 进行第一血糖值的测量。  [0035] In order to prepare to measure the first blood glucose level, it is predetermined to be 2 hours. Thus, the measurement of the first blood glucose level was performed 2 hours after the subject ingested the glucose solution.
[0036] 细化地, 所述步骤 S3中, 所述决定所述受试对象患有糖尿病的风险程度的步骤 具体包括:  [0036] In detail, in the step S3, the step of determining the risk level of the subject having diabetes includes:
[0037] 对所述受试对象为男性或未怀孕的女性执行以下步骤:  [0037] Performing the following steps on the subject who is male or not pregnant:
[0038] A、 判断所述空腹血糖值是否小于 100毫克 /分升, 若是, 则执行步骤 B, 若否, 则执行步骤 D;  [0038] A, determine whether the fasting blood glucose value is less than 100 mg / deciliter, and if so, step B is performed, and if not, step D is performed;
[0039] B、 判断所述第一血糖值是否小于 140毫克 /分升, 若是, 则决定所述风险程度 为低度风险, 若否, 则执行步骤 C;  [0039] B, determining whether the first blood glucose level is less than 140 mg / deciliter, and if so, determining that the risk level is a low risk, if not, performing step C;
[0040] C、 判断所述第一血糖值是否在 140至 199毫克 /分升之间, 若是, 则决定所述风 险程度为中度风险, 若否, 则决定所述风险程度为高度风险; [0040] C, determining whether the first blood glucose level is between 140 and 199 mg / deciliter, and if so, determining the wind The degree of risk is moderate risk, if not, the degree of risk is determined to be a high risk;
[0041] D、 判断所述空腹血糖值是否在 100至 125毫克 /分升之间, 若是, 则执行步骤 E[0041] D, determining whether the fasting blood glucose value is between 100 and 125 mg / deciliter, and if so, performing step E
, 若否, 则执行步骤 G; If not, execute step G;
[0042] E、 判断所述第一血糖值是否小于 140毫克 /分升, 若是, 则决定所述风险程度 为中度风险, 若否, 则执行步骤 F; [0042] E, determining whether the first blood glucose level is less than 140 mg / deciliter, and if so, determining that the risk level is moderate risk, and if not, performing step F;
[0043] F、 判断所述第一血糖值是否在 140至 199毫克 /分升之间, 若是, 则决定所述风 险程度为中度风险, 若否, 则决定所述风险程度为高度风险; [0043] F, determining whether the first blood glucose level is between 140 and 199 mg / deciliter, and if so, determining that the risk level is a moderate risk, and if not, determining that the risk level is a high risk;
[0044] G、 判断所述空腹血糖值是否在 126毫克 /分升以上, 若是, 则执行步骤 H, 若否[0044] G, determining whether the fasting blood glucose level is above 126 mg / deciliter, and if so, performing step H, if no
, 则结束; Then ends;
[0045] H、 判断所述第一血糖值是否小于 140毫克 /分升, 若是, 则决定所述风险程度 为中度风险, 若否, 则执行步骤 I;  [0045] H, determining whether the first blood glucose level is less than 140 mg / deciliter, and if so, determining that the risk level is moderate risk, and if not, performing step I;
[0046] I、 判断所述第一血糖值是否在 140至 199毫克 /分升之间, 若是, 则决定所述风 险程度为高度风险, 若否, 则决定所述风险程度为高度风险。 [0046] 1. Determine whether the first blood glucose level is between 140 and 199 mg / deciliter, and if so, determine that the risk level is a high risk, and if not, determine the risk level as a high risk.
[0047] 上述步骤的执行结果可理解为: [0047] The execution result of the above steps can be understood as:
[0048] 若空腹血糖值小于 100毫克 /分升, 且第一血糖值小于 140毫克 /分升, 则决定风 险程度为低度风险;  [0048] If the fasting blood glucose level is less than 100 mg/dl and the first blood glucose value is less than 140 mg/dl, then the risk level is determined to be a low risk;
[0049] 若空腹血糖值小于 100毫克 /分升, 且第一血糖值在 140至 199毫克 /分升之间, 则 决定风险程度为中度风险;  [0049] If the fasting blood glucose level is less than 100 mg/dl and the first blood glucose value is between 140 and 199 mg/dl, the risk level is determined to be a moderate risk;
[0050] 若空腹血糖值小于 100毫克 /分升, 且第一血糖值在 200毫克 /分升以上, 则决定 风险程度为高度风险; [0050] If the fasting blood glucose level is less than 100 mg/dl and the first blood glucose level is above 200 mg/dl, then the risk level is determined to be a high risk;
[0051] 若空腹血糖值在 100至 125毫克 /分升之间, 且第一血糖值小于 140毫克 /分升, 则 决定该风险程度为中度风险;  [0051] if the fasting blood glucose value is between 100 and 125 mg / deciliter, and the first blood glucose value is less than 140 mg / deciliter, the degree of risk is determined to be a moderate risk;
[0052] 若空腹血糖值在 100至 125毫克 /分升之间, 且第一血糖值在 140至 199毫克 /分升 之间, 则决定该风险程度为中度风险; [0052] if the fasting blood glucose value is between 100 and 125 mg / deciliter, and the first blood glucose value is between 140 and 199 mg / deciliter, the degree of risk is determined to be a moderate risk;
[0053] 若空腹血糖值在 100至 125毫克 /分升之间, 且第一血糖值在 200毫克 /分升以上, 则决定风险程度为高度风险; [0053] If the fasting blood glucose level is between 100 and 125 mg / deciliter, and the first blood glucose level is above 200 mg / deciliter, the degree of risk is determined to be a high risk;
[0054] 若空腹血糖值在 126毫克 /分升以上, 且第一血糖值小于 140毫克 /分升, 则决定 风险程度为中度风险; [0055] 若空腹血糖值在 126毫克 /分升以上, 且第一血糖值在 140至 199毫克 /分升之间, 则决定风险程度为高度风险; [0054] If the fasting blood glucose level is above 126 mg/dl, and the first blood glucose level is less than 140 mg/dl, the risk level is determined to be moderate risk; [0055] If the fasting blood glucose level is above 126 mg/dl, and the first blood glucose value is between 140 and 199 mg/dl, the risk level is determined to be a high risk;
[0056] 若空腹血糖值在 126毫克 /分升以上, 且第一血糖值在 200毫克 /分升以上, 则决 定风险程度为高度风险。  [0056] If the fasting blood glucose level is above 126 mg / deciliter and the first blood glucose level is above 200 mg / deciliter, then the degree of risk is determined to be a high risk.
[0057] 这样, 通过上述对受试对象为男性或未怀孕的女性的执行步骤, 可使得男性或 未怀孕的女性能够清楚准确地知道自己患有糖尿病的风险程度, 这对于不具有 专业医疗知识的普通人来说, 有利于提高他们对于检测结果所代表的糖尿病风 险程度的理解, 便于他们及吋治疗, 避免错失宝贵的治疗吋机。  [0057] Thus, by performing the above-described steps for the female subject or the female who is not pregnant, the male or the non-pregnant female can clearly and accurately know the degree of risk of having diabetes, which does not have professional medical knowledge. Ordinary people will help to improve their understanding of the degree of diabetes risk represented by the test results, to facilitate their treatment, and to avoid missing valuable treatment opportunities.
[0058] 同理, 细化地, 所述步骤 S3中, 所述决定所述受试对象患有糖尿病的风险程度 的步骤具体包括:  [0058] In the same manner, in the step S3, the step of determining the risk level of the subject having diabetes includes:
[0059] 对所述受试对象为怀孕的女性执行以下步骤:  [0059] Performing the following steps on the female subject who is pregnant:
[0060] 判断所述空腹血糖值是否大于 95毫克 /分升且经过所述预定吋间的所述第一血 糖值是否大于预设值;  [0060] determining whether the fasting blood glucose level is greater than 95 mg / deciliter and whether the first blood sugar value passing the predetermined time is greater than a preset value;
[0061] 若是, 则决定所述风险程度为高度风险; [0061] If yes, determining that the risk level is a high risk;
[0062] 若否, 则决定所述风险程度为低度风险或中度风险。 [0062] If not, it is determined that the risk level is a low risk or a medium risk.
[0063] 其中, 经过所述预定吋间的所述第一血糖值是否大于预设值, 具有以下三种情 况, 即:  [0063] wherein, whether the first blood glucose level after the predetermined time interval is greater than a preset value, has the following three situations, namely:
[0064] 一、 经过预定吋间为 1小吋的第一血糖值大于 180毫克 /分升;  [0064] 1. The first blood glucose level of 1 hour after the predetermined daytime is greater than 180 mg/dl;
[0065] 二、 经过预定吋间为 2小吋的第一血糖值大于 155毫克 /分升; [0065] 2. The first blood glucose level of 2 hours after the predetermined daytime is greater than 155 mg/dl;
[0066] 三、 经过预定吋间为 3小吋的第一血糖值大于 140毫克 /分升。 [0066] 3. The first blood glucose level of 3 hours after the predetermined daytime is greater than 140 mg/dl.
[0067] 这样, 当空腹血糖值大于 95毫克 /分升, 且经过预定吋间为 1小吋的第一血糖值 大于 180毫克 /分升吋, 决定所述风险程度为高度风险; [0067] Thus, when the fasting blood glucose level is greater than 95 mg/dl, and the first blood glucose value is less than 180 mg/dl after a predetermined daytime of 1 hour, the risk level is determined to be a high risk;
[0068] 当空腹血糖值大于 95毫克 /分升, 且经过预定吋间为 2小吋的第一血糖值大于 15[0068] When the fasting blood glucose value is greater than 95 mg / deciliter, and the first blood glucose value is less than 15 after a predetermined daytime of 2 hours
5毫克 /分升吋, 决定所述风险程度为高度风险; 5 mg / dl, determining that the risk level is a high risk;
[0069] 当空腹血糖值大于 95毫克 /分升, 且经过预定吋间为 3小吋的第一血糖值大于 14[0069] When the fasting blood glucose level is greater than 95 mg/dl, and the first blood glucose value is greater than 14 after a predetermined daytime of 3 hours
0毫克 /分升吋, 决定所述风险程度为高度风险; 0 mg / dl, determining that the risk level is a high risk;
[0070] 此外, 还可以是, 所述步骤 S3中, 所述决定所述受试对象患有糖尿病的风险程 度的步骤具体包括: [0071] 对所述受试对象为怀孕的女性执行以下步骤: [0070] In addition, in the step S3, the step of determining the risk degree of the subject having diabetes may specifically include: [0071] Perform the following steps on the female subject who is pregnant:
[0072] 判断经过第一预定吋间的所述第一血糖值是否大于第一预设值且经过第二预定 吋间的所述第一血糖值是否大于第二预设值;  [0072] determining whether the first blood glucose level after the first predetermined time interval is greater than a first preset value and the first blood glucose value after the second predetermined time interval is greater than a second preset value;
[0073] 若是, 则决定所述风险程度为高度风险; [0073] if yes, determining that the risk level is a high risk;
[0074] 若否, 则决定所述风险程度为低度风险或中度风险。 [0074] If not, it is determined that the risk level is a low risk or a moderate risk.
[0075] 其中, 第一预定吋间与第二预定吋间不同, 第一预设值与第二预设值不同。  [0075] wherein, the first predetermined time is different from the second predetermined time, and the first preset value is different from the second preset value.
[0076] 具体地, 第一预定吋间可为 1小吋或 2小吋, 第二预定吋间可为 3小吋, 第一预 设值可为 180毫克 /分升或 155毫克 /分升, 第二预设值可为 140毫克 /分升, 这样, 可以有: [0076] Specifically, the first predetermined time may be 1 hour or 2 hours, and the second predetermined time may be 3 hours, and the first preset value may be 180 mg/dl or 155 mg/dl. The second preset value can be 140 mg / dl, so that you can have:
[0077] 当经过第一预定吋间为 1小吋的所述第一血糖值大于 180毫克 /分升且经过第二 预定吋间为 3小吋的所述第一血糖值大于 140毫克 /分升吋, 决定所述风险程度为 高度风险;  [0077] the first blood glucose level is greater than 180 mg/dl when the first predetermined time interval is 1 hour, and the first blood glucose value is greater than 140 mg/minute after the second predetermined day is 3 hours. Ascending, determining that the risk level is a high risk;
[0078] 当经过第一预定吋间为 2小吋的所述第一血糖值大于 155毫克 /分升且经过第二 预定吋间为 3小吋的所述第一血糖值大于 140毫克 /分升吋, 决定所述风险程度为 高度风险。  [0078] the first blood glucose level is greater than 155 mg/dl when the first predetermined day is 2 hours, and the first blood glucose value is greater than 140 mg/min after the second predetermined day is 3 hours. Ascension, the degree of risk is determined to be a high risk.
[0079] 还可以是, 第一预定吋间可为 1小吋, 第二预定吋间可为 2小吋, 第一预设值可 为 180毫克 /分升, 第二预设值可为 155毫克 /分升, 这样, 可以有:  [0079] It may also be that the first predetermined time may be 1 hour, the second predetermined time may be 2 hours, the first preset value may be 180 mg/dl, and the second preset value may be 155. Mg/dl, so that you can have:
[0080] 当经过第一预定吋间为 1小吋的所述第一血糖值大于 180毫克 /分升且经过第二 预定吋间为 2小吋的所述第一血糖值大于 155毫克 /分升吋, 决定所述风险程度为 高度风险。  [0080] the first blood glucose level is greater than 180 mg/dl when the first predetermined time interval is 1 hour, and the first blood glucose value is greater than 155 mg/minute after the second predetermined time interval is 2 hours. Ascension, the degree of risk is determined to be a high risk.
[0081] 这样, 通过上述对受试对象为怀孕的女性的执行步骤, 可使得怀孕的女性能够 清楚准确地知道自己患有糖尿病的风险程度, 这对于不具有专业医疗知识的普 通人来说, 有利于提高他们对于检测结果所代表的糖尿病风险程度的理解, 便 于她们及吋治疗, 避免错失宝贵的治疗吋机。  [0081] Thus, by performing the above-described steps for the female subject to be pregnant, the pregnant woman can clearly and accurately know the degree of risk of having diabetes, which is common to ordinary people who do not have professional medical knowledge. It helps to improve their understanding of the degree of diabetes risk represented by the test results, to facilitate their treatment, and to avoid missing valuable treatment opportunities.
[0082] 本实施例还提供了糖尿病检测系统 10, 包括:  [0082] The embodiment further provides a diabetes detection system 10, including:
[0083] 血糖测量装置 100, 用于获取所述受试对象的空腹血糖值及第一血糖值;  [0083] The blood glucose measuring device 100 is configured to acquire a fasting blood sugar level and a first blood sugar level of the subject;
[0084] 以及电子装置 110, 用于获取所述受试对象的生理信息和判断所述受试对象是 否摄取葡萄糖溶液, 且于接收所述受试对象所输入的已摄取葡萄糖溶液的确认 信息后, 经过预定吋间, 提示所述受试对象测量第一血糖值, 再根据所述受试 对象的生理信息、 空腹血糖值及第一血糖值, 决定所述受试对象患有糖尿病的 风险程度, 显示所述风险程度; And the electronic device 110, configured to acquire physiological information of the subject, determine whether the subject takes up the glucose solution, and receive confirmation of the ingested glucose solution input by the subject After the information, after the predetermined time, the subject is prompted to measure the first blood glucose level, and then the subject is determined to have diabetes according to the physiological information of the subject, the fasting blood glucose level and the first blood glucose level. The degree of risk, showing the degree of risk;
[0085] 所述电子装置 110和血糖测量装置 100连接。  [0085] The electronic device 110 is connected to the blood glucose measuring device 100.
[0086] 采用上述糖尿病检测系统 10进行检测吋, 其先经由电子装置 110获取受试对象 的生理信息和空腹血糖值, 然后, 经由电子装置 110判断受试对象是否摄取葡萄 糖溶液, 如果是, 经由电子装置 110于接收受试对象所输入的已摄取葡萄糖溶液 的确认信息后, 经过预定吋间, 提示受试对象采用血糖测量装置 100测量第一血 糖值, 再经由电子装置 110根据受试对象的生理信息、 空腹血糖值及第一血糖值 , 决定受试对象患有糖尿病的风险程度, 并经由电子装置 110将该风险程度显示 给普通人。 因此, 通过上述糖尿病检测装置, 普通人可以实现简单、 容易地知 道自己患有糖尿病的风险程度, 有利于受试对象自行检测糖尿病。  [0086] The above-described diabetes detection system 10 performs detection, which first acquires the physiological information of the subject and the fasting blood glucose level via the electronic device 110, and then determines whether the subject takes the glucose solution via the electronic device 110, and if so, via After receiving the confirmation information of the ingested glucose solution input by the subject, the electronic device 110 prompts the subject to measure the first blood glucose level by using the blood glucose measuring device 100, and then, according to the subject, via the electronic device 110. The physiological information, the fasting blood glucose level, and the first blood glucose level determine the degree of risk of the subject having diabetes, and the risk level is displayed to the ordinary person via the electronic device 110. Therefore, with the above-described diabetes detecting device, the average person can realize the risk of having diabetes easily and easily, and it is advantageous for the subject to self-detect diabetes.
[0087] 细化地, 为了使得上述糖尿病检测方法适用的受试对象更为广泛, 生理信息包 括男性、 未怀孕的女性和怀孕的女性。  [0087] In detail, in order to make the above-mentioned diabetes detection method applicable to a wider range of subjects, physiological information includes males, non-pregnant women, and pregnant women.
[0088] 为了便于电子装置 110和血糖测量装置 100之间的信息传递, 电子装置 110和血 糖测量装置 100通过无线通信 120的方式来发送和接收信息。 In order to facilitate the transfer of information between the electronic device 110 and the blood glucose measuring device 100, the electronic device 110 and the blood glucose measuring device 100 transmit and receive information by way of wireless communication 120.
[0089] 具体地, 血糖检测装置可以为血糖机或血糖测试仪。 [0089] Specifically, the blood glucose detecting device may be a blood glucose meter or a blood glucose tester.
[0090] 细化地, 所述无线通信 120包括红外线通信、 蓝牙、 ZigBee、 GSM、 CDMA、 T [0090] In detail, the wireless communication 120 includes infrared communication, Bluetooth, ZigBee, GSM, CDMA, T
D-SCDMA、 WCDMA、 近场通信的任意一项或多项。 Any one or more of D-SCDMA, WCDMA, near field communication.
[0091] 细化地, 电子装置 110为手机、 平板电脑或电脑。 [0091] In detail, the electronic device 110 is a mobile phone, a tablet computer or a computer.
[0092] 以上仅为本发明的较佳实施例而已, 并不用以限制本发明, 凡在本发明的精神 和原则之内所作的任何修改、 等同替换和改进等, 均应包含在本发明的保护范 围之内。  The above are only the preferred embodiments of the present invention, and are not intended to limit the present invention. Any modifications, equivalents, and improvements made within the spirit and scope of the present invention should be included in the present invention. Within the scope of protection.

Claims

权利要求书  Claim
[权利要求 1] 一种糖尿病检测方法, 用于检测受试对象患有糖尿病的风险, 其特征 在于, 包括以下步骤:  [Claim 1] A method for detecting diabetes, for detecting a risk of diabetes in a subject, comprising the steps of:
51、 获取所述受试对象的生理信息和空腹血糖值; 51. Obtain physiological information and a fasting blood glucose value of the subject;
52、 判断所述受试对象是否摄取葡萄糖溶液; 52. Determine whether the subject takes up a glucose solution;
若是, 则执行步骤 S3;  If yes, step S3 is performed;
若否, 则返回步骤 S1 ;  If no, return to step S1;
53、 于接收所述受试对象所输入的已摄取葡萄糖溶液的确认信息后, 经过预定吋间, 提示所述受试对象测量第一血糖值, 再根据所述受试 对象的生理信息、 空腹血糖值及第一血糖值, 决定所述受试对象患有 糖尿病的风险程度, 显示所述风险程度。  53. After receiving the confirmation information of the ingested glucose solution input by the subject, after the predetermined time, the subject is prompted to measure the first blood glucose level, and according to the physiological information of the subject, the fasting The blood glucose level and the first blood glucose level determine the degree of risk of the subject having diabetes, indicating the degree of the risk.
[权利要求 2] 如权利要求 1所述的糖尿病检测方法, 其特征在于, 所述生理信息包 括男性、 未怀孕的女性和怀孕的女性。  [Claim 2] The diabetes detecting method according to claim 1, wherein the physiological information includes a male, a non-pregnant female, and a pregnant female.
[权利要求 3] 如权利要求 2所述的糖尿病检测方法, 其特征在于, 所述预定吋间为 2 小吋。 [Claim 3] The diabetes detecting method according to claim 2, wherein the predetermined time is 2 hours.
[权利要求 4] 如权利要求 2所述的糖尿病检测方法, 其特征在于, 所述步骤 S3中, 所述决定所述受试对象患有糖尿病的风险程度的步骤具体包括: 对所述受试对象为男性或未怀孕的女性执行以下步骤:  The method of detecting diabetes according to claim 2, wherein in the step S3, the step of determining the degree of risk of the subject having diabetes includes: The following steps are performed for women who are male or not pregnant:
A、 判断所述空腹血糖值是否小于 100毫克 /分升, 若是, 则执行步骤 B, 若否, 则执行步骤 D;  A, determine whether the fasting blood glucose value is less than 100 mg / deciliter, and if so, step B is performed, and if not, step D is performed;
B、 判断所述第一血糖值是否小于 140毫克 /分升, 若是, 则决定所述 风险程度为低度风险, 若否, 则执行步骤 C;  B, determining whether the first blood glucose level is less than 140 mg / deciliter, and if so, determining that the risk level is a low risk, if not, performing step C;
C、 判断所述第一血糖值是否在 140至 199毫克 /分升之间, 若是, 则决 定所述风险程度为中度风险, 若否, 则决定所述风险程度为高度风险  C. determining whether the first blood glucose level is between 140 and 199 mg / deciliter, and if so, determining that the risk level is a moderate risk, and if not, determining that the risk level is a high risk
D、 判断所述空腹血糖值是否在 100至 125毫克 /分升之间, 若是, 则执 行步骤 E, 若否, 则执行步骤 G; D, determining whether the fasting blood glucose value is between 100 and 125 mg / deciliter, and if so, executing step E, if not, executing step G;
E、 判断所述第一血糖值是否小于 140毫克 /分升, 若是, 则决定所述 风险程度为中度风险, 若否, 则执行步骤 F; E. determining whether the first blood glucose level is less than 140 mg/dl, and if so, determining the The risk level is moderate risk, if not, proceed to step F;
F、 判断所述第一血糖值是否在 140至 199毫克 /分升之间, 若是, 则决 定所述风险程度为中度风险, 若否, 则决定所述风险程度为高度风险  F. determining whether the first blood glucose level is between 140 and 199 mg / deciliter, and if so, determining that the risk level is a moderate risk, and if not, determining that the risk level is a high risk
G、 判断所述空腹血糖值是否在 126毫克 /分升以上, 若是, 则执行步 骤 H, 若否, 则结束; G. determining whether the fasting blood glucose level is above 126 mg / deciliter, and if so, performing step H, and if not, ending;
H、 判断所述第一血糖值是否小于 140毫克 /分升, 若是, 则决定所述 风险程度为中度风险, 若否, 则执行步骤 I;  H, determining whether the first blood glucose level is less than 140 mg / deciliter, and if so, determining that the risk level is a moderate risk, and if not, performing step I;
I、 判断所述第一血糖值是否在 140至 199毫克 /分升之间, 若是, 则决 定所述风险程度为高度风险, 若否, 则决定所述风险程度为高度风险  I. determining whether the first blood glucose level is between 140 and 199 mg / deciliter, and if so, determining that the risk level is a high risk, and if not, determining that the risk level is a high risk
[权利要求 5] 如权利要求 2所述的糖尿病检测方法, 其特征在于, 所述步骤 S3中, 所述决定所述受试对象患有糖尿病的风险程度的步骤具体包括: 对所述受试对象为怀孕的女性执行以下步骤: The method of detecting diabetes according to claim 2, wherein in the step S3, the step of determining the degree of risk of the subject having diabetes includes: The subject is pregnant female performing the following steps:
判断所述空腹血糖值是否大于 95毫克 /分升且经过所述预定吋间的所 述第一血糖值是否大于预设值;  Determining whether the fasting blood glucose level is greater than 95 mg / deciliter and whether the first blood glucose level passing the predetermined time is greater than a preset value;
若是, 则决定所述风险程度为高度风险;  If yes, it is determined that the risk level is a high risk;
若否, 则决定所述风险程度为低度风险或中度风险。  If not, it is determined that the risk level is a low risk or a moderate risk.
[权利要求 6] 如权利要求 2所述的糖尿病检测方法, 其特征在于, 所述步骤 S3中, 所述决定所述受试对象患有糖尿病的风险程度的步骤具体包括: 对所述受试对象为怀孕的女性执行以下步骤: The method of detecting diabetes according to claim 2, wherein in the step S3, the step of determining the degree of risk of the subject having diabetes includes: The subject is pregnant female performing the following steps:
判断经过第一预定吋间的所述第一血糖值是否大于第一预设值且经过 第二预定吋间的所述第一血糖值是否大于第二预设值;  Determining whether the first blood glucose level after the first predetermined time interval is greater than a first preset value and the first blood glucose value passing the second predetermined time is greater than a second preset value;
若是, 则决定所述风险程度为高度风险;  If yes, it is determined that the risk level is a high risk;
若否, 则决定所述风险程度为低度风险或中度风险。  If not, it is determined that the risk level is a low risk or a moderate risk.
[权利要求 7] 糖尿病检测系统, 其特征在于, 包括: [Claim 7] The diabetes detection system, comprising:
血糖测量装置, 用于获取所述受试对象的空腹血糖值及第一血糖值; 以及电子装置, 用于获取所述受试对象的生理信息和判断所述受试对 象是否摄取葡萄糖溶液, 且于接收所述受试对象所输入的已摄取葡萄 糖溶液的确认信息后, 经过预定吋间, 提示所述受试对象测量第一血 糖值, 再根据所述受试对象的生理信息、 空腹血糖值及第一血糖值, 决定所述受试对象患有糖尿病的风险程度, 显示所述风险程度; 所述电子装置和血糖测量装置连接。 a blood glucose measuring device, configured to acquire a fasting blood sugar level and a first blood sugar level of the subject; and an electronic device, configured to acquire physiological information of the subject and determine the pair of the test If the glucose solution is ingested, and after receiving the confirmation information of the ingested glucose solution input by the subject, the predetermined time is displayed, the subject is prompted to measure the first blood glucose level, and then according to the subject The physiological information, the fasting blood glucose level and the first blood glucose level determine the degree of risk of the subject having diabetes, indicating the degree of the risk; and the electronic device is connected to the blood glucose measuring device.
[权利要求 8] 如权利要求 7所述的糖尿病检测系统, 其特征在于, 所述生理信息包 括男性、 未怀孕的女性和怀孕的女性。 [Claim 8] The diabetes detecting system according to claim 7, wherein the physiological information includes a male, a non-pregnant female, and a pregnant female.
[权利要求 9] 如权利要求 7所述的糖尿病检测系统, 其特征在于, 所述电子装置和 血糖测量装置通过无线通信的方式来发送和接收信息。 [Claim 9] The diabetes detecting system according to claim 7, wherein the electronic device and the blood glucose measuring device transmit and receive information by wireless communication.
[权利要求 10] 如权利要求 9所述的糖尿病检测系统, 其特征在于, 所述无线通信包 括红外线通信、 蓝牙、 ZigBee、 GSM、 CDMA、 TD-SCDMA、 WCD[Claim 10] The diabetes detecting system according to claim 9, wherein the wireless communication comprises infrared communication, Bluetooth, ZigBee, GSM, CDMA, TD-SCDMA, WCD
MA、 近场通信的任意一项或多项。 Any one or more of MA, near field communication.
[权利要求 11] 如权利要求 7所述的糖尿病检测系统, 其特征在于, 所述电子装置为 手机、 平板电脑或电脑。 [Claim 11] The diabetes detecting system according to claim 7, wherein the electronic device is a mobile phone, a tablet computer, or a computer.
PCT/CN2016/112371 2016-12-27 2016-12-27 Diabetes detection method and diabetes detection system WO2018119663A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2016/112371 WO2018119663A1 (en) 2016-12-27 2016-12-27 Diabetes detection method and diabetes detection system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2016/112371 WO2018119663A1 (en) 2016-12-27 2016-12-27 Diabetes detection method and diabetes detection system

Publications (1)

Publication Number Publication Date
WO2018119663A1 true WO2018119663A1 (en) 2018-07-05

Family

ID=62706554

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/112371 WO2018119663A1 (en) 2016-12-27 2016-12-27 Diabetes detection method and diabetes detection system

Country Status (1)

Country Link
WO (1) WO2018119663A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3624134A1 (en) * 2018-09-11 2020-03-18 Samsung Electronics Co., Ltd. Apparatus and method for health care
US11517223B2 (en) 2018-12-13 2022-12-06 Samsung Electronics Co., Ltd. Apparatus and method for estimating blood glucose

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1676093A (en) * 2005-04-27 2005-10-05 张厚玫 Diabetes monitoring instrument
CN2850518Y (en) * 2005-10-24 2006-12-27 北京软测科技有限公司 Portable diabetes condition monitoring apparatus
EP2130487A1 (en) * 2008-06-03 2009-12-09 Microlife Intellectual Property GmbH Glucose meter, a system with a glucose meter, method for operating a glucose meter and a computer program product
CN101835418A (en) * 2007-08-23 2010-09-15 智能传感器遥控医疗有限公司 Glucose tolerance test device
CN103040475A (en) * 2011-10-17 2013-04-17 希森美康株式会社 Glucose tolerance analyzer, glucose tolerance analyzing system, and storage medium
CN104224191A (en) * 2013-06-06 2014-12-24 埃森·费尔索夫 Blood glucose monitor

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1676093A (en) * 2005-04-27 2005-10-05 张厚玫 Diabetes monitoring instrument
CN2850518Y (en) * 2005-10-24 2006-12-27 北京软测科技有限公司 Portable diabetes condition monitoring apparatus
CN101835418A (en) * 2007-08-23 2010-09-15 智能传感器遥控医疗有限公司 Glucose tolerance test device
EP2130487A1 (en) * 2008-06-03 2009-12-09 Microlife Intellectual Property GmbH Glucose meter, a system with a glucose meter, method for operating a glucose meter and a computer program product
CN103040475A (en) * 2011-10-17 2013-04-17 希森美康株式会社 Glucose tolerance analyzer, glucose tolerance analyzing system, and storage medium
CN104224191A (en) * 2013-06-06 2014-12-24 埃森·费尔索夫 Blood glucose monitor

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3624134A1 (en) * 2018-09-11 2020-03-18 Samsung Electronics Co., Ltd. Apparatus and method for health care
US11147521B2 (en) 2018-09-11 2021-10-19 Samsung Electronics Co., Ltd. Apparatus and method for health care
US11517223B2 (en) 2018-12-13 2022-12-06 Samsung Electronics Co., Ltd. Apparatus and method for estimating blood glucose

Similar Documents

Publication Publication Date Title
Neubrand et al. Factors associated with completion of the human papillomavirus vaccine series
Agarwal et al. Location not quantity of blood pressure measurements predicts mortality in hemodialysis patients
WO2018119663A1 (en) Diabetes detection method and diabetes detection system
Head et al. Ambulatory blood pressure monitoring
CN103654858A (en) Portable stroke early-warning monitor
Thomas et al. A glucose meter accuracy and precision comparison: The freestyle flash versus the accu-chek advantage, accu-chek compact plus, ascensia contour, and the BD logic
EP2915129A1 (en) Wireless communication authentication for medical monitoring device
CN104208867A (en) Sit-up tester
CN202477681U (en) Optical fiber sensor-based digestive tract pressure measuring device for medical clinic
Takahashi et al. Validation of the OMRON M6 Comfort (HEM-7321-E) upper arm blood pressure monitor, in oscillometry mode, for clinic use and self measurement in a general population, according to the European Society of Hypertension International Protocol revision. 2010
CN106638852A (en) Body weight management and analysis system and method applied to smart healthy toilet bowl
CN210427579U (en) Sugar tolerance quantitative evaluation device based on expiration detection
WO2018233107A1 (en) Weight measuring method of weight detection device, and weight detection device
cheol Jeong et al. Introducing a practical approach for non-invasive blood pressure monitoring during home-based telerehabilitation exercise program
CN202477650U (en) Anti-memorization visual chart
Jacob et al. Salivary diagnostics reloaded
CN206002551U (en) ABO is positive and negative and RhD antigens bloodtypes identify combiner
CN101264012A (en) Blood pressure determination data processing device and data analysis method thereof
CN102735709B (en) Method for rapidly detecting sildenafil citrate illegally added in health food products and traditional Chinese medicine preparations
WO2014094245A1 (en) Sphygmomanometer system and blood pressure measurement method therefor
CN201939355U (en) Gastrointestinal pressure-measuring device for internal medicine
CN205411167U (en) High blood pressure telemedicine system
Yamanoglu et al. A comparison of noninvasive methods for early detection of hemorrhage: inferior vena cava ultrasonography and spectrophotometric hemoglobin levels
CN204007903U (en) Automatically remind clinical thermometer
CN202099287U (en) Device for detecting Coxsackie virus A16 type

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16925412

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16925412

Country of ref document: EP

Kind code of ref document: A1